Codexis, Inc. (CDXS) Eyes Raizen With Latest Enzymes: Pfizer Inc. (PFE), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

Page 1 of 2

Aside from a former partnership with Royal Dutch Shell plc (ADR) (NYSE:RDS-A), industrial biotechnology company Codexis, Inc. (NASDAQ:CDXS) has had much more success courting pharmaceutical partners than those involved in fuels and chemicals. The company’s enzymes and pharmaceutical intermediates are featured in processes for innovator products such as Januvia/Janumet from Merck & Co., Inc. (NYSE:MRK), former innovator products such as Lipitor from Pfizer Inc. (NYSE:PFE), and generics from Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and DSM. The company’s fortunes may change soon with the unveiling of its latest generation of cellulase enzymes. Is a commercial partner just around the corner?

What’s a cellulase enzyme?
Before we get into the news let’s take a step back and address the elephant in the room: What the heck is a cellulase enzyme?! An enzyme is a complex molecule that improves or enables a chemical reaction at a lower level of energy, thus saving time and money. For instance, Codexis and Merck & Co., Inc. (NYSE:MRK)’s new process for Januvia increased yield by 13%, productivity by 53%, and reduced waste by 19%.

Pfizer Inc. (NYSE:PFE)Processes in chemical engineering can be completed in three ways: by increasing the amount of heat or pressure, aka “brute force”; by utilizing a catalyst or enzyme; or by a combination of each. Therefore, the point of cellulase enzymes is to break down cellulose and hemicellulose, natural polymers found in biomass, into their basic units during a “brute force” process called hydrolysis. Depending on the type of biomass these units can be sugars such as glucose (corn), sucrose (sugarcane), or xylose (wood crops).

When you hear about cellulosic biofuels and wonder why they haven’t gone mainstream yet, cellulase enzymes are to blame. While enzymes increase process yield and profitability and reduce waste, their efficiency is affected by operating parameters such as pH, temperature, and pressure. Cellulosic fuels and chemicals won’t be economically viable until enzymes can unlock the sugars mentioned above at a low enough cost. The possibility of incredibly efficient industrial processes has been “a few years away” for a long time as enzymes were coaxed to work in a wider range of operating parameters. Now companies such as Codexis, Inc. (NASDAQ:CDXS), Novozymes, Genencor, and Dyadic are finally breaking down the door.

X marks the spot
CEO John Nichols mentioned that the company’s CodeXyme enzymes had achieved 85% conversion of corn stover at 1% loading (1 g enzyme/100 g cellulose) on the conference call discussing 2012 financial results a few weeks ago. No one seemed to care at the time given the dim 2013 outlook, but characteristics like that would have given the company the market’s leading enzymes. I made a cautionary note of this overlooked statement in the earnings recap, although admittedly I’m a bit more in tune with the industry as a bioprocess engineer and investor. Of course, leading enzymes mean little without a commercial partner.

Whether Nichols meant to hint at the latest generation of cellulase enzymes or couldn’t contain his excitement will never be known, but Codexis, Inc. (NASDAQ:CDXS) released more data on the products Tuesday. Depending on the source of biomass the company’s CodeXyme 4 and CodeXyme 4X enzymes increase performance by 10%-20% over CodeXyme 3 generation enzymes. The “X” in “4X” stands for xylose, a sugar the company was able to unlock in its latest generation enzyme:

Source: Codexis

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!